New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery

Advanced Drug Delivery Reviews
Alejandro SosnikDiego A Chiappetta

Abstract

Tuberculosis (TB) is the second most deadly infectious disease. Despite potentially curative pharmacotherapies being available for over 50 years, the length of the treatment and the pill burden can hamper patient lifestyle. Thus, low compliance and adherence to administration schedules remain the main reasons for therapeutic failure and contribute to the development of multi-drug-resistant (MDR) strains. Pediatric patients constitute a high risk population. Most of the first-line drugs are not commercially available in pediatric form. The design of novel antibiotics attempts to overcome drug resistance, to shorten the treatment course and to reduce drug interactions with antiretroviral therapies. On the other hand, the existing anti-TB drugs are still effective. Overcoming technological drawbacks of these therapeutic agents as well as improving the effectiveness of the drug by targeting the infection reservoirs remains the central aims of Pharmaceutical Technology. In this framework, nanotechnologies appear as one of the most promising approaches for the development of more effective and compliant medicines. The present review thoroughly overviews the state-of-the-art in the development of nano-based drug delivery systems for e...Continue Reading

References

Jun 1, 1990·Antimicrobial Agents and Chemotherapy·S P KlemensR S Ginsberg
Jan 1, 1986·Therapeutic Drug Monitoring·J R KoupA L Smith
Sep 1, 1968·Journal of Medicinal Chemistry·N MaggiC R Pasqualucci
Jul 1, 1995·Journal of Microencapsulation·C P Jain, S P Vyas
Jan 1, 1996·Annual Review of Microbiology·G A Rook, R Hernandez-Pando
Aug 15, 1997·Annals of Internal Medicine·J SahaiD W Cameron
Mar 17, 2001·Advanced Drug Delivery Reviews·K KataokaY Nagasaki
Aug 10, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·D L H PoelmaJ F van Iwaarden
Aug 15, 2002·International Journal of Pharmaceutics·Ernesto ReverchonGiovanna Della Porta
Jan 29, 2003·International Journal of Pharmaceutics·R JevprasesphantA D'Emanuele
Jul 15, 2003·Clinical Microbiology Reviews·Issar Smith
Sep 19, 2003·Lancet·Thomas R FriedenChristopher Dye
Dec 31, 2003·International Journal of Pharmaceutics·S P VyasParamjit Singh
Jan 7, 2004·International Journal of Pharmaceutics·Jeffrey O-H ShamRaimar Löbenberg
Mar 11, 2004·International Journal of Pharmaceutics·Junzo SekiTadanori Mayumi
May 4, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·B EvrardD Cataldo
May 7, 2004·The Journal of Antimicrobial Chemotherapy·Rajesh Pandey, G K Khuller
Sep 2, 2004·Nature Reviews. Drug Discovery·Barrett E Rabinow
Mar 12, 2005·The Journal of Antimicrobial Chemotherapy·Rajesh Pandey, G K Khuller
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Svetlana GelperinaLeonid Heifets
Sep 13, 2005·International Journal of Antimicrobial Agents·Zahoor AhmadG K Khuller
Nov 1, 2005·Tuberculosis·Rajesh PandeyG K Khuller
Nov 24, 2005·International Journal of Pharmaceutics·Donald E Owens, Nicholas A Peppas
Nov 26, 2005·Expert Review of Anti-infective Therapy·Kim Connelly Smith, Barbara J Seaworth
Nov 29, 2005·Advanced Drug Delivery Reviews·Antony D'Emanuele, David Attwood
Nov 29, 2005·International Journal of Pharmaceutics·C VermehrenJ Hansen
Dec 17, 2005·Journal of Colloid and Interface Science·Aihua WuYongke He
Dec 24, 2005·Expert Opinion on Drug Delivery·Hamidreza Montazeri Aliabadi, Afsaneh Lavasanifar
Jan 26, 2006·European Journal of Pharmacology·Ulrich PisonDavid A Groneberg
Apr 7, 2006·The Journal of Antimicrobial Chemotherapy·Rajesh Pandey, G K Khuller
May 12, 2006·Archiv der Pharmazie·Marcia SilvaElizabeth I Ferreira
Oct 20, 2006·International Journal of Pharmaceutics·M S El-RidySameh Abd El-Alim
Oct 20, 2006·Journal of Drug Targeting·Palanirajan Vijayaraj KumarNarendra K Jain
Dec 2, 2006·International Journal of Pharmaceutics·Thorsteinn Loftsson, Dominique Duchêne
Jan 18, 2007·The Journal of Pharmacy and Pharmacology·Sumio ChonoKazuhiro Morimoto
May 8, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Diego A Chiappetta, Alejandro Sosnik
Jul 3, 2007·Advanced Drug Delivery Reviews·Filippos KesisoglouYunhui Wu
Jul 3, 2007·Advanced Drug Delivery Reviews·Marcus E Brewster, Thorsteinn Loftsson
Aug 11, 2007·Journal of Pharmaceutical Sciences·Harikrishna DevalapallyMansoor M Amiji
Aug 22, 2007·International Journal of Pharmaceutics·Kamalinder K Singh, Sharvani K Vingkar

❮ Previous
Next ❯

Citations

Jun 19, 2010·Current HIV/AIDS Reports·Umesh G Lalloo, Anish Ambaram
Mar 30, 2012·The Journal of Infectious Diseases·Michael UhlinMarkus Maeurer
Aug 26, 2011·Journal of the Royal Society, Interface·Marcela A MorettonAlejandro Sosnik
Oct 24, 2012·International Journal of Nanomedicine·Bullo SaifullahSamer Hasan Hussein Al Ali
Nov 3, 2010·Nanomedicine·Stefaan J H Soenen, Marcel De Cuyper
Oct 27, 2011·Nanomedicine·Marina PinheiroSalette Reis
Aug 1, 2012·Nanomedicine·Min SunGuangxi Zhai
Apr 16, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Indu Pal Kaur, Harinder Singh
Jul 3, 2013·Pharmacology & Therapeutics·Andrew J Thorley, Teresa D Tetley
Jul 9, 2013·International Journal of Pharmaceutics·May S FreagOssama Y Abdallah
Aug 8, 2013·Future Medicinal Chemistry·Cedric P OwensCelia W Goulding
Sep 21, 2012·Journal of Microencapsulation·Hugo Costa, Ana Grenha
Mar 15, 2015·Journal of Drug Targeting·Sanaul MustafaV Kusum Devi
Jan 20, 2012·Expert Opinion on Drug Delivery·Alejandro SosnikDiego A Chiappetta
Aug 29, 2012·Expert Opinion on Drug Delivery·Abhinay SharmaAtul Kumar Johri
Dec 30, 2014·Journal of Pharmaceutical Sciences·Rahul S KalhapureThirumala Govender
Jun 13, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anne HellerAchim Goepferich
Apr 7, 2012·Drug Discovery Today·Devyani DubeSuresh P Vyas
Jul 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ae Jung Huh, Young Jik Kwon
Feb 19, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Rajesh Pandey, Zahoor Ahmad
Jul 16, 2010·Colloids and Surfaces. B, Biointerfaces·Marcela A MorettonAlejandro Sosnik
Nov 17, 2009·Advanced Drug Delivery Reviews·Alejandro Sosnik, Mansoor Amiji
Oct 20, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Yanna HaoBuyun Zhou
Oct 20, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Narjara SilveiraPriscilla V Finotelli
Jul 24, 2015·The Journal of Antimicrobial Chemotherapy·M Moreno-SastreJ L Pedraz
Dec 1, 2010·Journal of Applied Toxicology : JAT·Anna Giulia CattaneoGiovanni Bernardini
Sep 4, 2015·Angewandte Chemie·Peter LeidingerClaus Feldmann
Jun 22, 2015·Journal of Molecular Graphics & Modelling·Reinaldo G BelliniBruno A C Horta
May 10, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Adrián Cambronero-RojasCarolina Gómez-Gaete
May 1, 2015·Integrative Biology : Quantitative Biosciences From Nano to Macro·Jennifer J LindermanDenise E Kirschner
Sep 18, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·John Gar Yan ChanDaniela Traini
Jan 8, 2013·Nano Today·Lara YildirimerAlexander M Seifalian
Aug 13, 2013·Advanced Drug Delivery Reviews·Fernanda AndradeBruno Sarmento
May 14, 2014·Advanced Drug Delivery Reviews·Alejandro Sosnik, Angel M Carcaboso
Jun 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohammed M MehannaNazik A Elgindy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.